United States · Series D startup

Who invested in OncoResponse

3 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$44Mraised across 3 rounds since 2016, from 3 sources

$7.0MSeries A$23MSeries A$14MSeries D
Latest round
Series D, $14MMay 2023
Biggest round
$23MSeries A · Mar 2017
Investors
11
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2017201820192020202120222023
$7.0MSeries A$23MSeries A$14MSeries D
First round
Series A, $7.0M
Oct 2016
Biggest round
$23M
Series A · Mar 2017
Usual gap between rounds
6.2 years
the median of 2

The rounds

  1. May 2023
    Series D$14M2 new2 returning

    Source recordedSEC filing: $14M sold, first sale May 2023

  2. Mar 2017
    Series A$23M8 new1 returning

    Reported by FinSMEsSEC filing: $29M sold, first sale Sept 2015

  3. Oct 2016
    Series A$7.0M1 new

    Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2016Series A2017Series D2023GreatPoint VenturesCanaanARCH Venture PartnersRedmile GroupArchAlexandria Real EstateHelsinnBaxaltaHT Family OfficeMarsh Rice University

Everyone who backed them

GreatPoint VenturesVC firm3rounds
CanaanVC firm2rounds
Redmile GroupVC firm1round
ArchHedge fund1round
Alexandria Real EstateGrowth equity1round
HelsinnVC firm1round
BaxaltaCorporate VC1round
HT Family Officeno record of our own yet1round
Marsh Rice Universityno record of our own yet1round
MD Andersonno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about OncoResponse

Who invested in OncoResponse?

OncoResponse's investors include GreatPoint Ventures, Canaan, ARCH Venture Partners, Redmile Group and Arch, and 6 more on record.

How much has OncoResponse raised?

OncoResponse has raised $44M across 3 rounds since 2016.

When did OncoResponse last raise?

OncoResponse's most recent round was a Series D of $14M in May 2023.

What was OncoResponse's biggest round?

OncoResponse's largest round on record is $23M (Series A), in Mar 2017.

Who backed OncoResponse first?

OncoResponse's first round on record, in Oct 2016, was backed by GreatPoint Ventures.

What stage is OncoResponse at?

OncoResponse's latest named round is a Series D, in May 2023.

Where is OncoResponse based?

OncoResponse is based in the United States.

Companies like OncoResponse

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.